Opinion

Video

Exploring Therapies for Platinum Sensitive & Platinum-Resistant Ovarian Cancer

A medical expert discusses efficacy of approaches such as carboplatin doublets, checkpoint inhibitors, and PARP inhibitors for patients with platinum sensitive and platinum-resistant ovarian cancer.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Sundar Jagannath
1 expert in this video
4 experts in this video
4 experts in this video
Dr Caroline Vovan
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo